4
non-substituted thiazonaphthalimide 5 (Ka = 104.0 M-1).18 The
substitution of the thiazole ring by the mesomeric electron-
donating amino group decreases the affinity for the double helix
by a factor of 2-3.5. Moreover, compound 5 also displays the
largest fluorescence quenching upon ct-DNA binding.
Acknowledgments
The authors thank Pierre-Alain Bayle for his contribution in
the recording of NMR data and Colette Lebrun for ESI-MS
spectrum. This research was supported by the Labex ARCANE
(Grant ANR-11-LABX-0003-01).
References
1. Braña, M. F.; Castellano, J. M.; Roldan, C. M.; Santos, A.; Vazquez, D.;
Jimenez, A. Cancer Chemother. Pharmacol. 1980, 4 (1), 61.
2. Kamal, A.; Bolla, N. R.; Srikanth, P. S.; Srivastava, A. K. Expert Opin.
Ther. Pat. 2013, 23 (3), 299.
3. Quintana-Espinoza, P.; Martin-Acosta, P.; Amesty, A. ; Martin-
Rodriguez, P.; Lorenzo-Castrillejo, I.; Fernandez-Perez, L.; Machin,
Espinoza, P.; Garcia-Luis, J.; Amesty, A.; Martin-Rodriguez, P. ; Lorenzo-
Castrillejo, I.; Ravelo, A. G.; Fernandez-Perez, L.; Machin, F.; Estevez-
Braun, A. Bioorg. Med. Chem. 2013, 21, 6484.
4. Banerjee, S.; Veale, E. B.; Phelan, C. M.; Murphy, S. A.; Tocci, G. M.;
Gillespie, L. J.; Frimannsson, D. O.; Kelly, J. M.; Gunnlaugsson, T. Chem.
Soc. Rev. 2013, 42 (4), 1601; Duke, R.M.; Veale, E.B.; Pferrer, F.M.;
Kruger, P.E.; Gunnlaugsson, T. Chem. Soc. Rev. 2010, 39, 3936.
5. Roldan, C. M.; Braña, M. F.; Berlango, J. M. 4-acylamino-n-
phenylbutyramides - useful as pharmaceuticals. Patent DE2318136 A1,
1973.
6. Sami, S. M.; Dorr, R. T.; Solyom, A. M.; Alberts, D.S.; Remers, W.A. J.
Med. Chem. 1995, 38, 983; Sami, S. M.; Dorr, R. T.; Alberts, D.S.;
Solyom, A. M.; Remers, W.A. J. Med. Chem. 1996, 39, 4978.
Figure 3. A) Titration of compound 5 (2.5 M) (HEPES buffer 10
mM, pH 7.0, NaCl 10 mM) at 298 K. Fluorescence upon excitation
at 356 nm as a function of ct-DNA (bp). B) Corresponding evolution
of the fluorescence at 418 nm; circles are experimental points and the
line represents calculated data with the program SPECFIT (logKa =
4.0).
7. Braña, M. F.; Cacho, M.; García, M. A.; de Pascual-Teresa, B.; Ramos,
A.; Domínguez, M. T.; Pozuelo, J. M.; Abradelo, C.; Rey-Stolle, M. F.;
Yuste, M.; Báñez-Coronel, M.; Lacal, J. C. J. Med. Chem. 2004, 47 (6),
1391.
Table 1. Association constants of the naphthalimide derivatives with
ct-DNA at pH 7.
8. Li, Z.; Yang, Q.; Qian, X. Bioorg. Med. Chem. Lett. 2005, 15 (7), 1769.
9. Qian, X.; Li, Z.; Yang, Q. Bioorg. Med. Chem. 2007, 15 (21), 6846.
Compound
logKa
5
7
8
10. Ancel, L.; Gateau, C.; Lebrun, C.; Delangle, P. Inorg. Chem. 2013, 52,
552.
4.00(3)
3.45(7)
3.67(3)
11. Bonnet, C.S.; Devocelle, M.; Gunnlaugsson, T. Org. Biomol. Chem.
2012, 10, 126; Bonnet, C.S.; Devocelle, M.; Gunnlaugsson, T. Chem.
Com. 2008, 4552; Shuvaev, S.; Starck, M.; Parker, D. Chem. Eur. J. 2017,
23, 9974.
The melting temperature of double-stranded DNA can be used
to partially characterize the mode of interaction of aromatic
compounds with DNA.19 No significant alteration of the melting
temperature was observed in the presence of thiazonaphthalimide
compounds 5, 7 and 8, presumably indicating that none of the
three aromatic compounds interacts with DNA via an
intercalative process between the base pairs of DNA (see ESI,
Fig. S12). Indeed, although an intercalative process is mentioned
in the literature for the interaction between thiazonaphthalimide
derivatives and ct-DNA, little evidence has been provided.
12. Peters, A; T.; Bide, M.J. Dyes and Pigments 1985, 6, 267.
13. Prajapati, N.P., Vekariya, R. H.; Borad, A.; Patel, H.D. RSC Adv. 2014,
4, 60176; Deshmukh, R.; Thakur A. S.; Jha A. K.; Deshmukh R. Int. J. Res.
Pharm. Chem. 2011, 1, 329; Munirajasekhar, D.; HimajaM.; Mali sunil
V. Int. Res. J. Pharm. 2011, 2, 114; Rawat, A. G. S.; Gupta, A. J Curr
Pharm Res 2010, 3, 13; Malik, J. K.; Manvi, F.; Nanjwade B.; Singh S.
Drug Invent. Today 2009, 1, 32.
In summary, we have reported the synthesis and unambiguous
characterization of angular thiazonaphthalimide derivatives. The
formation of linear regioisomers was revealed to not be possible,
which is in accordance with the poor reactivity of position 2 in
the ring. Compounds 5, 7 and 8 strongly bind to ct-DNA, with no
significant evolution of the ct-DNA melting temperature upon
binding, which suggests a non-intercalative process. The largest
affinity and fluorescence quenching is observed for the non-
substituted ring. The next step will be to graft compound 6a to
amino groups found in peptides or proteins to obtain fluorescent
probes sensitive to DNA.
14. Prasad, J. V.; Panapoulous, A.; Rubin, J. R. Tetrahedron Lett. 2000,
41 (21), 4065.
15. Soderback, E Justus Liebig’s Annalen der Chemie, 1919, 419 (3),
217.
16. Katritzky, A. R.; Rogovoy, B. V.; Chassaing, C.; Vvedensky, V.;
Forood, B.; Flatt, B.; Nakai, H. J. Heterocycl. Chem. 2000, 37 (6), 1655.